{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:55:29Z","timestamp":1780700129656,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004728","name":"Department of Biotechnology, School of Bio-Sciences and Technology (SBST), VIT University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ejmech.2017.09.076","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T16:31:02Z","timestamp":1507739462000},"page":"417-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential"],"prefix":"10.1016","volume":"141","author":[{"given":"A.","family":"Manikandan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Moharil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sathishkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mu\u00f1oz-Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.09.076_bib1","doi-asserted-by":"crossref","first-page":"12627","DOI":"10.1002\/anie.201505173","article-title":"An indoxyl-based strategy for the synthesis of indolines and indolenines","volume":"54","author":"Yu","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2017.09.076_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007997709110217","article-title":"Antihypertensive and saluretic properties of the indoline and isoindoline series","volume":"5","author":"Beregi","year":"1977","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2017.09.076_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0002-8703(83)90119-9","article-title":"Pharmacokinetics and clinical pharmacology of Indapamide","volume":"106","author":"Frank","year":"1983","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejmech.2017.09.076_bib4","series-title":"ABC of Hypertension","isbn-type":"print","first-page":"83","author":"Gareth Beevers","year":"2014","ISBN":"https:\/\/id.crossref.org\/isbn\/9781118592564"},{"key":"10.1016\/j.ejmech.2017.09.076_bib5","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1021\/jm301411g","article-title":"Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer\u2019s disease","volume":"55","author":"Inessa","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.076_bib6","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3892\/mmr.2014.2552","article-title":"Preliminary detection of the anti-tumour activity of indoline-2,3-dione derivative DH-12a targeting aminopeptidase N","volume":"10","author":"Cui","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2017.09.076_bib7","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1310459110","article-title":"Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to \u03b2-lactam antibiotics","volume":"110","author":"Podoll","year":"2013","journal-title":"PNAS United States of America"},{"key":"10.1016\/j.ejmech.2017.09.076_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(16)30073-4","article-title":"Global burden of stroke and risk factors in 188 countries, during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"15","author":"Feigin","year":"2016","journal-title":"The. Lancet Neurology"},{"key":"10.1016\/j.ejmech.2017.09.076_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/srep00717","article-title":"Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides","volume":"2","author":"Geoffrey","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2017.09.076_bib10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/HJH.0b013e3282f465d2","article-title":"Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype","volume":"26","author":"van Esch","year":"2008","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ejmech.2017.09.076_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0735-1097(96)00098-8","article-title":"The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure","volume":"28","author":"Andersson","year":"1996","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ejmech.2017.09.076_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00002512-200421020-00001","article-title":"Drugs for stroke recovery: the example of amphetamines","volume":"21","author":"Martinsson","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejmech.2017.09.076_bib13","isbn-type":"print","first-page":"10","volume":"5","author":"Fillardi","year":"2015","ISBN":"https:\/\/id.crossref.org\/isbn\/9783319097879"},{"key":"10.1016\/j.ejmech.2017.09.076_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/1470320314568438","article-title":"Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats","volume":"16","author":"Sarah","year":"2015","journal-title":"J.\u00a0Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.ejmech.2017.09.076_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.HYP.0000151323.93372.f5","article-title":"Selective angiotensin-converting enzyme C-Domain inhibition is sufficient to prevent angiotensin I\u2013Induced vasoconstriction","volume":"45","author":"van Esch","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejmech.2017.09.076_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1470320313489206","article-title":"C-domain-selective inhibition of angiotensin-converting enzyme","volume":"14","author":"Mario","year":"2013","journal-title":"J.\u00a0Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.ejmech.2017.09.076_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.07.061","article-title":"Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE","volume":"577","author":"Ceconi","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.09.076_bib18","series-title":"Goodman & Gilman's. The Pharmacological Basis of Therapeutics","isbn-type":"print","article-title":"Chapter 30. Renin and angiotensin","author":"Jackson","year":"2006","ISBN":"https:\/\/id.crossref.org\/isbn\/0071422803"},{"key":"10.1016\/j.ejmech.2017.09.076_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","article-title":"Role of oxidative stress in cardiovascular diseases","volume":"18","author":"Dhalla","year":"2000","journal-title":"J.\u00a0Hypertens."},{"key":"10.1016\/j.ejmech.2017.09.076_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.20060218","article-title":"Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?","volume":"203","author":"Heinecke","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2017.09.076_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCRESAHA.110.224618","article-title":"Lipid oxidation, and cardiovascular disease: introduction to a review series","volume":"107","author":"McIntyre","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2017.09.076_bib22","article-title":"Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and\/or prevention?","volume":"514623","author":"Fredric","year":"2011","journal-title":"Int. J. Inflamm."},{"key":"10.1016\/j.ejmech.2017.09.076_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1527-3466.2005.tb00160.x","article-title":"Oxidative stress, and cardiovascular disease: antioxidants and unresolved issues","volume":"23","author":"Sachidanandam","year":"2005","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejmech.2017.09.076_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/oxim.2.5.9441","article-title":"Oxidative stress as a mediator of cardiovascular disease","volume":"2","author":"Elahi","year":"2009","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2017.09.076_bib25","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1538-7836.2010.04031.x","article-title":"Coagulation factor XI as a novel target for antithrombotic treatment","volume":"8","author":"L\u00f6wenberg","year":"2010","journal-title":"J.\u00a0Thrombosis Haemostasis"},{"key":"10.1016\/j.ejmech.2017.09.076_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0749-0690(05)70113-0","article-title":"Thrombolysis and antithrombotic therapy for coronary artery disease","volume":"17","author":"Aronow","year":"2001","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.ejmech.2017.09.076_bib27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/th14-02-0184","article-title":"Clot properties, and cardiovascular disease","volume":"112","author":"Bridge","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejmech.2017.09.076_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00041433-199910000-00009","article-title":"Coagulation abnormalities, and cardiovascular disease","volume":"10","author":"DeLoughery","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ejmech.2017.09.076_bib29","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.3390\/ijms150814077","article-title":"Angiotensin I-Converting enzyme (ACE) inhibitory activity and ACE inhibitory peptides of salmon (Salmo salar) protein hydrolysates obtained by human and porcine gastrointestinal enzymes","volume":"15","author":"Darewicz","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2017.09.076_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00280-016-3227-z","article-title":"Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents","volume":"79","author":"Manikandan","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.09.076_bib31","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.bmc.2017.01.007","article-title":"Molecular docking, Discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors\/antibacterial agents","volume":"25","author":"Manikandan","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.09.076_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1504\/IJBRA.2016.080722","article-title":"Molecular docking and in\u00a0vitro evaluations of Hippocampus trimaculatus (seahorse) extracts as the anti-inflammatory compounds","volume":"12","author":"Manikandan","year":"2016","journal-title":"Int. J. Bioinforma. Res. Appl."},{"key":"10.1016\/j.ejmech.2017.09.076_bib33","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1021\/ac901775h","article-title":"Colorimetric, high-throughput assay for screening angiotensin I-converting enzyme inhibitors","volume":"81","author":"Jimsheena","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2017.09.076_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-4-14","article-title":"Development of an in\u00a0vitro model to study clot lysis activity of thrombolytic drugs","volume":"4","author":"Prasad","year":"2006","journal-title":"Thrombosis J."},{"key":"10.1016\/j.ejmech.2017.09.076_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-017-0342-3","article-title":"Efficacy and rationale of 2-(4-phenylquinolin-2-yl) phenols as COX-2 inhibitors; an approach to emergent the small molecules as the anti-inflammatory and analgesic therapeutics","volume":"25","author":"Manikandan","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejmech.2017.09.076_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1248\/cpb.53.281","article-title":"Determination of in\u00a0vitro antioxidant and radical scavenging activities of propofol","volume":"53","author":"Gulcin","year":"2005","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2017.09.076_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity, and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.09.076_bib38","first-page":"195727","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.ejmech.2017.09.076_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejps.2008.02.121","article-title":"Synthesis, in\u00a0vitro and in\u00a0vivo characterization of novel ethyl dioxy phosphate prodrug of propofol","volume":"34","author":"Kumpulainen","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2017.09.076_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.59566\/IJBS.2008.4089","article-title":"Free radicals, antioxidants in disease and health","volume":"4","author":"Pham-Huy","year":"2008","journal-title":"Int. J. Biomed. Sci. IJBS"},{"key":"10.1016\/j.ejmech.2017.09.076_bib41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jth.12125","article-title":"Oxidized high-density lipoprotein reduces blood clot firmness","volume":"11","author":"Talens","year":"2013","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.ejmech.2017.09.076_bib42","doi-asserted-by":"crossref","first-page":"e41966","DOI":"10.1371\/journal.pone.0041966","article-title":"Identification of fibrin clot-bound plasma proteins","volume":"7","author":"Talens","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejmech.2017.09.076_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","article-title":"Oxidative stress and antioxidant defense","volume":"5","author":"Birben","year":"2012","journal-title":"The. World Allergy Organ. J."},{"key":"10.1016\/j.ejmech.2017.09.076_bib44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1677\/ERC-09-0020","article-title":"Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is, therefore, a potential mutagen for this organ","volume":"16","author":"Driessens","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejmech.2017.09.076_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jbt.20289","article-title":"Indole and its alkyl-substituted derivatives protect erythrocyte and DNA against radical-induced oxidation","volume":"23","author":"Zhao","year":"2009","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejmech.2017.09.076_bib46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.013","article-title":"Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke","volume":"23","author":"Kate","year":"2014","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejmech.2017.09.076_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000447539","article-title":"Thrombolytic action of apixaban on intra-atrial thrombus developed after previous treatment with warfarin: a case report","author":"Valero","year":"2016","journal-title":"Med. Princ. Pract.25"},{"key":"10.1016\/j.ejmech.2017.09.076_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.15420\/aer.2011.3.1.40","article-title":"The potential role of edoxaban in stroke prevention guidelines","volume":"3","author":"Plunkett","year":"2014","journal-title":"Arrhythmia Electrophysiol. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417307912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:45:15Z","timestamp":1719510315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417307912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":48,"alternative-id":["S0223523417307912"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.076","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}